In 'Journeys in Leukemia: Innovations in Diagnosis and Treatment, ' delve deep into the latest breakthroughs in Acute Myeloid Leukemia (AML) research and clinical practice. This comprehensive collection of scientific journal articles illuminates cutting-edge diagnostic technologies and novel therapeutic approaches shaping the future of AML treatment. Explore revolutionary techniques such as multi-parametric flow cytometry for precise leukemic cell identification, CRISPR methods for detecting drug-resistant mutations, and nanopore sequencing for rapid gene mutation analysis. Discover the significant strides made in molecular monitoring, including minimal residual disease (MRD) assessments and the utilization of circulating tumor DNA (ctDNA) for real-time patient monitoring. The anthology also delves into the genetic and epigenetic underpinnings of AML, highlighting the prognostic values of miRNA and the impacts of DNA methylation. Compelling studies on PARP and TRPM2 gene expressions and novel biomarkers detected through high-throughput sequencing offer nuanced perspectives on patient prognosis and personalized treatment strategies. This anthology is an indispensable resource for clinicians, researchers, and students aiming to stay at the forefront of AML research, diagnosis, and treatment. Quality Research Publishing is dedicated to making knowledge more accessible to the general public by curating a topical compilation of the latest research on various subjects and providing plain language summaries. Each of the articles in this book is available individually and digitally without cost. However, we believe it is important for the contextualizing and sharing of educational and scientific work to curate this research in a way that is understandable and helpful to the average person seeking deeper knowledge of a particular subject. The research articles compiled for this book were published under a permissive Creative Commons license, are in th